Literature DB >> 12762359

A prediction rule to identify allocation of inpatient care in community-acquired pneumonia.

P P España1, A Capelastegui, J M Quintana, A Soto, I Gorordo, M García-Urbaneja, A Bilbao.   

Abstract

The current authors developed a new prediction rule based on the five risk classes defined by the Pneumonia Severity Index to identify allocation of inpatient care in community-acquired pneumonia. The decision to hospitalise in low-risk classes (I-III) was unquestionable, if the presence of one or more of the following were evident: arterial oxygen tension <8.0 kPa (60 mmHg), shock, decompensated coexisting illnesses, pleural effusion, inability to maintain oral intake, social problem, and lack of response to previous adequate empirical antibiotic therapy. The results at 18 months after implementation of this new prediction rule are reported in a series of 616 patients. The mortality rate was 0.5% in 221 patients treated as outpatients versus 8.9% in 395 patients treated as inpatients. Specific additional criteria for hospitalisation included in the prediction rule were present in 106 of the 178 low-risk patients treated as inpatients, whereas in the remaining 72, the decision to hospitalise was apparently unjustified by the prediction rule. These 72 patients showed a better outcome (significantly shorter hospitalisation, days on intravenous antibiotics, mortality, and complicated course) than high-risk patients and low-risk patients who met the additional specific criteria for deciding hospital admission. Therefore, admission in these low-risk patients might have been avoided by strict adherence to the new prediction rule. Another relevant finding was that the Pneumonia Severity Index alone did not identify all patients who needed to be admitted to the hospital.

Entities:  

Mesh:

Year:  2003        PMID: 12762359     DOI: 10.1183/09031936.03.00057302

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  12 in total

1.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

Review 2.  Changing needs of community-acquired pneumonia.

Authors:  Julio Alberto Ramirez; Antonio R Anzueto
Journal:  J Antimicrob Chemother       Date:  2011-04       Impact factor: 5.790

3.  Hospital admission decision for patients with community-acquired pneumonia.

Authors:  Stefano Aliberti; Paola Faverio; Francesco Blasi
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

4.  Hospital Treatment Costs and Factors Affecting These Costs in Community-Acquired Pneumonia.

Authors:  Fatma Tokgöz Akyıl; Armağan Hazar; İpek Erdem; Canan Pehlivan Öneş; Murat Yalçınsoy; İlim Irmak; Umut Sabri Kasapoğlu
Journal:  Turk Thorac J       Date:  2015-07-01

5.  Utility of two biomarkers for directing care among patients with non-severe community-acquired pneumonia.

Authors:  P P España; A Capelastegui; A Bilbao; R Diez; F Izquierdo; M J Lopez de Goicoetxea; J Gamazo; F Medel; J Salgado; I Gorostiaga; J M Quintana
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-05       Impact factor: 3.267

Review 6.  [Assessment, triage, and follow-up of a patient with: acute CAP COPD].

Authors:  K Faure
Journal:  Med Mal Infect       Date:  2006-11-07       Impact factor: 2.152

7.  Lysophosphatidylcholine as a prognostic marker in community-acquired pneumonia requiring hospitalization: a pilot study.

Authors:  W H Cho; H J Yeo; S H Yoon; S E Lee; D S Jeon; Y S Kim; S J Lee; E J Jo; J H Mok; M H Kim; K U Kim; K Lee; H K Park; M K Lee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-30       Impact factor: 3.267

8.  Etiology of community-acquired pneumonia in a population-based study: link between etiology and patients characteristics, process-of-care, clinical evolution and outcomes.

Authors:  Alberto Capelastegui; Pedro P España; Amaia Bilbao; Julio Gamazo; Federico Medel; Juan Salgado; Iñaki Gorostiaga; Maria Jose Lopez de Goicoechea; Inmaculada Gorordo; Cristobal Esteban; Lander Altube; Jose M Quintana
Journal:  BMC Infect Dis       Date:  2012-06-12       Impact factor: 3.090

9.  Low T3 syndrome is a strong predictor of poor outcomes in patients with community-acquired pneumonia.

Authors:  Jinliang Liu; Xuejie Wu; Fang Lu; Lifang Zhao; Lingxian Shi; Feng Xu
Journal:  Sci Rep       Date:  2016-03-01       Impact factor: 4.379

Review 10.  Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia.

Authors:  Mi Suk Lee; Jee Youn Oh; Cheol In Kang; Eu Suk Kim; Sunghoon Park; Chin Kook Rhee; Ji Ye Jung; Kyung Wook Jo; Eun Young Heo; Dong Ah Park; Gee Young Suh; Sungmin Kiem
Journal:  Infect Chemother       Date:  2018-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.